Bath & Body Works, Inc. (NYSE:BBWI) Stock Holdings Lowered by Fifth Third Bancorp

Fifth Third Bancorp reduced its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 70.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,498 shares of the company's stock after selling 10,478 shares during the quarter. Fifth Third Bancorp's holdings in Bath & Body Works were worth $174,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in BBWI. True Wealth Design LLC boosted its position in Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock worth $34,000 after purchasing an additional 1,054 shares in the last quarter. UMB Bank n.a. increased its position in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after purchasing an additional 335 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock worth $38,000 after buying an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works in the third quarter valued at $39,000. Finally, TD Private Client Wealth LLC lifted its position in Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock valued at $54,000 after buying an additional 331 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

Bath & Body Works stock traded up $0.76 during midday trading on Tuesday, reaching $38.76. The stock had a trading volume of 2,748,132 shares, compared to its average volume of 3,002,306. The stock has a market capitalization of $8.39 billion, a PE ratio of 9.45, a price-to-earnings-growth ratio of 1.01 and a beta of 1.83. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The stock's 50-day simple moving average is $37.67 and its 200 day simple moving average is $33.61.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the prior year, the business earned $0.48 earnings per share. The business's quarterly revenue was up 3.1% compared to the same quarter last year. Equities analysts predict that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were given a dividend of $0.20 per share. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.06%. Bath & Body Works's payout ratio is currently 19.51%.

Wall Street Analyst Weigh In

BBWI has been the topic of several analyst reports. Telsey Advisory Group reiterated an "outperform" rating and issued a $42.00 price objective on shares of Bath & Body Works in a research note on Monday, November 25th. Barclays boosted their price objective on Bath & Body Works from $28.00 to $34.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 26th. Piper Sandler lifted their price target on Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a report on Monday, January 6th. Morgan Stanley dropped their price objective on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a report on Thursday, November 21st. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Bath & Body Works from $39.00 to $41.00 and gave the company a "neutral" rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company's stock. Based on data from MarketBeat, Bath & Body Works has an average rating of "Moderate Buy" and a consensus price target of $43.19.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.